Concomitant Medications for Progressive Supranuclear Palsy: A Secondary Analysis of a Randomized Clinical Trial.,JAMA Neurology

当前位置： X-MOL 学术 › JAMA Neurol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Concomitant Medications for Progressive Supranuclear Palsy: A Secondary Analysis of a Randomized Clinical Trial.
JAMA Neurology ( IF 29.0 ) Pub Date : 2024-01-22 , DOI: 10.1001/jamaneurol.2023.5215
Jay M. Iyer ₁ , Douglas Gunzler ₂ , Anthony E. Lang ₃ , Lawrence I. Golbe ₄ , Alexander Pantelyat ₅ , Adam L. Boxer ₆ , Anne-Marie Wills ₇ ,

Affiliation

This secondary analysis of a randomized clinical trial examines changes in the progression of progressive supranuclear palsy (PSP) associated with 31 concomitant medication classes used by study participants over 1 year.

中文翻译：